Agilon Health (AGL)

Cost of Revenue

$5.92B

TTM · Period ending: · USD

AGL logo

AGL Cost of Revenue

Latest reported$5.92B
AGL TTM Cost of Revenue ($1.01B → $5.92B)
High-resolution chart · PNG

AGL cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Agilon Health Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
5,919,933,000
5,979,738,000
6,099,566,000
5,993,177,000
6,005,309,000
6,008,483,000
6,055,689,000
5,405,748,000
4,990,673,000
4,554,629,000
4,006,552,000
3,775,530,000
3,344,452,000
2,966,133,000
2,595,925,000
2,369,445,000
2,144,155,000
1,984,112,000
1,757,146,000
1,619,570,000
1,463,172,000
1,242,119,000
1,124,183,000
1,005,328,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.